Microengineered Liver Tissues for Drug Testing
Open accessThe DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Abstract
Drug-induced liver injury (DILI) is a leading cause of drug attrition. Significant and well-documented differences between animals and humans in liver pathways now necessitate the use of human-relevant in vitro liver models for testing new chemical entities during preclinical drug development. Consequently, several human liver models with various levels of in vivo-like complexity have been developed for assessment of drug metabolism, toxicity, and efficacy on liver diseases. Recent trends leverage engineering tools, such as those adapted from the semiconductor industry, to enable precise control over the microenvironment of liver cells and to allow for miniaturization into formats amenable for higher throughput drug screening. Integration of liver models into organs-on-a-chip devices, permitting crosstalk between tissue types, is actively being pursued to obtain a systems-level understanding of drug effects. Here, we review the major trends, challenges, and opportunities associated with development and implementation of engineered liver models created from primary cells, cell lines, and stem cell-derived hepatocyte-like cells. We also present key applications where such models are currently making an impact and highlight areas for improvement. In the future, engineered liver models will prove useful for selecting drugs that are efficacious, safer, and, in some cases, personalized for specific patient populations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in vitro liver systems typically use supraphysiologic concentrations of insulin/glucose and drug concentrations, and lack key elements of the liver microenvironment, including hemodynamics, transport, and multicellularity (5).”
From Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis (2016) · cites this paper as [5]
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Geometric Control of Cell Life and Death
Chen, C. S., Mrksich, M., Huang, S., Whitesides, G. M., & Ingber, D. E. (1997) · Science · doi:10.1126/science.276.5317.1425 · Cited by 4,657 · cited 1×
“In contrast, through the use of selective surface modification, microfabrication tools allow generation of heterogeneous surfaces that offer control over cell-ECM and cell-cell interactions with micrometer precision.(96,97) A variety of such micropatterning techniques are reviewed in other articles.”
BackgroundLutolf, M. P., & Hubbell, J. A. (2005) · Nature Biotechnology · doi:10.1038/nbt1055 · Cited by 4,551 · cited 2×
“Here, we focus on polyethylene-glycol (PEG)–based hydrogels, pioneered by Lutolf and Hubbell.(131) PEG hydrogels are of great interest for cell culture due to their biocompatibility, hydrophilicity, and ability to be customized by varying chain length (to control microporosity and thus mechanical properties) or by che…”
BackgroundRheinwatd, J. G., & Green, H. (1975) · Cell · doi:10.1016/s0092-8674(75)80001-8 · Cited by 4,537
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167 · cited 1×
“However, almost 90% of compounds that pass through preclinical drug screening end up failing during clinical trials, and one-third of these failures have been attributed to toxicity.(3) Furthermore, ~90% of withdrawals of drugs from the marketplace are due to toxicity issues.”
BackgroundMembrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340 · cited 1×
“Both uptake and efflux transporters, distributed over many organs, are now recognized as major contributors to overall drug disposition in the body.(163,164) Thus, a variety of in vitro models have been developed to assess transporter contributions.”
BackgroundHuman induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
Vascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170 · cited 1×
“More recently, a handful of groups have tested this so-called coculture effect on iHeps using non–liver NPCs such as murine embryonic Swiss-3T3 fibroblasts as well as a combination of MSCs (mesenchymal stem cells) and HUVECs (human umbilical vein endothelial cells).(89,90) Liver-inspired complex ECM mixtures and ECM d…”
BackgroundConcordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050 · cited 3×
“Yet, significant differences between animals and humans in liver functions lead to lack of concordance in drug responses for several drug classes.(6) The drawbacks with current in vitro models and live animal studies are key motivations underlying the development of more physiologically relevant in vitro models of the…”
BackgroundInfluentialFrom 3D cell culture to organs-on-chips
Huh, D., Hamilton, G. A., & Ingber, D. E. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.005 · Cited by 1,834 · cited 1×
“That being said, highly functional 2D models are being used to build the first generation organs-on-a-chip devices.(151) Thus, it appears that high liver functionality, stability of phenotype for Table 1.”
MethodMicroscale technologies for tissue engineering and biology
Khademhosseini, A., Langer, R., Borenstein, J., & Vacanti, J. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507681102 · Cited by 1,558 · cited 2×
“A variety of such micropatterning techniques are reviewed in other articles.(98,99) Briefly, photolithography allows patterning of photoresist (light-sensitive polymer) onto a silicon or glass wafer.”
BackgroundMethodEngineering cell shape and function
Singhvi, R., Kumar, A., Lopez, G. P., Stephanopoulos, G. N., Wang, D. I. C., Whitesides, G. M., & Ingber, D. E. (1994) · Science · doi:10.1126/science.8171320 · Cited by 1,453 · cited 2×
“Microfabrication tools have been used extensively to investigate biological phenomena in different model systems.98,100 In the case of the liver, Singhvi et al.101 demonstrated culture of rat hepatocytes on patterned self-assembled monolayers (SAMs) of alkanethiols with adsorbed fibronectin, which were surrounded by n…”
BackgroundHighly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells
Si-Tayeb, K., Noto, F. K., Nagaoka, M., Li, J., Battle, M. A., Duris, C., North, P. E., Dalton, S., & Duncan, S. A. (2010) · Hepatology · doi:10.1002/hep.23354 · Cited by 1,282
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280 · cited 10×
“PHHs, isolated from the human liver via collagenase perfusion, are widely considered to be the “gold standard” for use in constructing liver models for drug testing and other life science applications.(11,12) A recent study showed that addition of an antioxidant, N-acetylcysteine, and replacement of collagenase with L…”
BackgroundMethodInfluentialObach, R. S. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14938-0 · Cited by 1,232 · cited 2×
“In vitro models of the liver are often used throughout drug development for applications in drug disposition and drugdrug interactions (DDIs).(106,155,156) In particular, microsomes are used to evaluate which CYP450 enzymes metabolize a given class of compounds, suspension hepatocytes and some plated formats are used…”
BackgroundMicroscale culture of human liver cells for drug development
Khetani, S. R., & Bhatia, S. N. (2008) · Nature Biotechnology · doi:10.1038/nbt1361 · Cited by 1,219 · cited 12×
“In particular, PDMS stencils were initially used to pattern ECM, and then a PDMS gasket was used to provide 24 distinct wells for drug dosing over the MPCCs.74 However, since PDMS is a porous and hydrophobic material, drugs and other hydrophobic molecules in culture medium (i.e., proteins) had a tendency to get soaked…”
BackgroundMethodInfluentialSelf-citationIdiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054 · cited 2×
“Of such toxicities, drug-induced liver injury (DILI) is the most common cause of acute liver failures in the United States alone and is a leading cause of both the prelaunch and postmarket attrition of pharmaceuticals.(4) For instance, DILI accounts for ~40% of the drugs that fail during clinical trials and has been l…”
BackgroundBhatia, S. N., Balis, U. J., Yarmush, M. L., & Toner, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.1883 · Cited by 890 · cited 5×
“the historical perspective and advances that have been made in this field.(11,12,15,81,82) Briefly, the most popular culture configurations are ones in which confluent monolayers of primary hepatocytes are attached to adsorbed or gelled rat tail collagen I (widely and cheaply available) and then overlaid with another…”
BackgroundInfluentialAn extracellular matrix microarray for probing cellular differentiation
Flaim, C. J., Chien, S., & Bhatia, S. N. (2005) · Nature Methods · doi:10.1038/nmeth736 · Cited by 803 · cited 1×
“Liver-inspired complex ECM mixtures and ECM derived directly from the liver have also been shown to induce key hepatic functions.(91,92) Finally, supplementation of culture medium with soluble factors, such as hormones (i.”
BackgroundWilkening, S., Stahl, F., & Bader, A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.8.1035 · Cited by 794 · cited 9×
“Evaluation of hepatotoxicity using multiparameter cell feature analysis measured by fluorescent imaging was implemented by O’Brien et al.181 using HepG2 and was later extended by Xu et al.180 to short-term ECM sandwich cultures of PHHs.”
BackgroundInfluentialGerets, H. H. J., Tilmant, K., Gerin, B., Chanteux, H., Depelchin, B. O., Dhalluin, S., & Atienzar, F. A. (2012) · Cell Biology and Toxicology · doi:10.1007/s10565-011-9208-4 · Cited by 698 · cited 7×
“Gerets et al.,8 on the other hand, reported a sensitivity of only 6.3% for HepG2 cells using 16 liver toxic drugs with 100% specificity using five non–liver toxins.”
BackgroundMethodInfluentialO’Brien, P. J., Irwin, W., Diaz, D., Howard-Cofield, E., Krejsa, C. M., Slaughter, M. R., Gao, B., Kaludercic, N., Angeline, A., Bernardi, P., et al. (2006) · Archives of Toxicology · doi:10.1007/s00204-006-0091-3 · Cited by 609 · cited 2×
“Evaluation of hepatotoxicity using multiparameter cell feature analysis measured by fluorescent imaging was implemented by O’Brien et al.181 using HepG2 and was later extended by Xu et al.180 to short-term ECM sandwich cultures of PHHs.”
MethodRaeber, G. P., Lutolf, M. P., & Hubbell, J. A. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.050682 · Cited by 573 · cited 1×
“PEG hydrogels also allow for the incorporation of moieties that are sensitive to cell-secreted proteases, thereby allowing cellular remodeling of the gels.(132) In the case of the liver, the Bhatia group has cultured primary hepatocytes and supportive NPCs (fibroblasts, endothelia) in PEG hydrogels containing the RGD…”
BackgroundDirect Reprogramming of Human Fibroblasts to Functional and Expandable Hepatocytes
Huang, P., Zhang, L., Gao, Y., He, Z., Yao, D., Wu, Z., Cen, J., Chen, X., Liu, C., Hu, Y., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.01.003 · Cited by 560 · cited 1×
“Some more recent approaches include stimulation with small molecules that can reduce fetal markers in iHeps,(62) deriving iHeps from PHHs to maintain the native epigenetic modifications,(52) and direct lineage reprogramming of fibroblasts into iHeps using key hepatic fate and maturation transcription factors.(58,63) D…”
BackgroundControlling cell interactions by micropatterning in co-cultures: Hepatocytes and 3T3 fibroblasts
Bhatia, S. N., Yarmush, M. L., & Toner, M. (1997) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199702)34:2<189::aid-jbm8>3.0.co;2-m · Cited by 547
GUGUENGUILLOUZO, C., CLEMENT, B., BAFFET, G., BEAUMONT, C., MORELCHANY, E., GLAISE, D., & GUILLOUZO, A. (1983) · Experimental Cell Research · doi:10.1016/0014-4827(83)90107-6 · Cited by 519 · cited 1×
“Coculture of hepatocytes with NPCs likely maintains hepatic functions due to the concordant impact on the local ECM, soluble microenvironment, and cell-cell interactions.(82,102) Furthermore, there is evidence that coculture of different liver cell types in the same device/ well allows better stability and functionali…”
BackgroundLee, P. J., Hung, P. J., & Lee, L. P. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21360 · Cited by 509 · cited 2×
“Picture of a single bioreactor on the plate along with phase-contrast micrograph of hepatocyte aggregates in five separate channels with interspersed perfusion channels and slits (D).(142) This platform is commercially available through EMD Millipore (Billerica, MA).”
MethodEngineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets
Ohashi, K., Yokoyama, T., Yamato, M., Kuge, H., Kanehiro, H., Tsutsumi, M., Amanuma, T., Iwata, H., Yang, J., Okano, T., et al. (2007) · Nature Medicine · doi:10.1038/nm1576 · Cited by 507 · cited 1×
“Thermo-responsive substrates have also been used to create micropatterned cocultures with better control over placement and subsequent removal of specific cell types.(117,118) However, such “dynamic” cell culture substrates lead to a reduction in throughput for drug testing, and specific training of personnel on handl…”
MethodEfficient generation of hepatocyte-like cells from human induced pluripotent stem cells
Song, Z., Cai, J., Liu, Y., Zhao, D., Yong, J., Duo, S., Song, X., Guo, Y., Zhao, Y., Qin, H., et al. (2009) · Cell Research · doi:10.1038/cr.2009.107 · Cited by 499
Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury
Xu, J. J., Henstock, P. V., Dunn, M. C., Smith, A. R., Chabot, J. R., & de Graaf, D. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn109 · Cited by 492 · cited 8×
“using HepG2 and was later extended by Xu et al.(180) to short-term ECM sandwich cultures of PHHs.”
BackgroundMethodInfluentialAbboud, G., & Kaplowitz, N. (2007) · Drug Safety · doi:10.2165/00002018-200730040-00001 · Cited by 479
LeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477 · cited 4×
“These studies revealed that cell-cell contact played a critical role in modulating hepatocyte functions by several fold, likely due to cadherin interactions as observed in other studies.(81) As in studies by Guguen-Guillouzo et al,(102) physical contact with stromal cells (i.”
BackgroundResultInfluentialFabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogels
Tsang, V. L., Chen, A. A., Cho, L. M., Jadin, K. D., Sah, R. L., DeLong, S., West, J. L., & Bhatia, S. N. (2007) · The FASEB Journal · doi:10.1096/fj.06-7117com · Cited by 462
Generation of Functional Human Hepatic Endoderm From Human Induced Pluripotent Stem Cells
Sullivan, G. J., Hay, D. C., Park, I.-H., Fletcher, J., Hannoun, Z., Payne, C. M., Dalgetty, D., Black, J. R., Ross, J. A., Samuel, K., et al. (2010) · Hepatology · doi:10.1002/hep.23335 · Cited by 445
A microfluidic 3D hepatocyte chip for drug toxicity testing
Toh, Y.-C., Lim, T. C., Tai, D., Xiao, G., van Noort, D., & Yu, H. (2009) · Lab on a Chip · doi:10.1039/b900912d · Cited by 419 · cited 2×
“A similar device design, using a micropillar array to allow diffusion of soluble factors to hepatocyte aggregates, was implemented by Toh et al.(143) (3D HepaTox Chip).”
MethodDeconstructing the Drug Development Process: The New Face of Innovation
Kaitin, K. I. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.293 · Cited by 418 · cited 2×
“Many arguments have been made that pharmaceutical companies will save millions, if not billions, of dollars by using in vitro models to eliminate toxic compounds from the pipeline and/or to design better drugs prior to reaching human clinical trials or the marketplace where failures can be very costly.(1,2) However, i…”
BackgroundDeLeve, L. D., Wang, X., & Guo, Y. (2008) · Hepatology · doi:10.1002/hep.22351 · Cited by 408 · cited 3×
“Another group has demonstrated that coculture with freshly isolated LSECs was able to decrease HSC activation, but coculture with LSECs that had lost their differentiated state had no effect on HSCs.(121) While the proof of concept for complex cocultures has been demonstrated, reproducibility across devices with respe…”
BackgroundMicromechanical control of cell–cell interactions
Hui, E. E., & Bhatia, S. N. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608660104 · Cited by 390 · cited 2×
“showed that contact with fibroblasts was necessary for ~18 h, followed by stimulation of hepatocytes with secreted fibroblast factors that are likely to be labile such that the fibroblasts need to be present close to the hepatocytes (<400 microns) to enable a complete rescue of the hepatic phenotype.(116) Thus, fibrob…”
BackgroundMethodReconfigurable microfluidic hanging drop network for multi-tissue interaction and analysis
Frey, O., Misun, P. M., Fluri, D. A., Hengstler, J. G., & Hierlemann, A. (2014) · Nature Communications · doi:10.1038/ncomms5250 · Cited by 387 · cited 2×
“Indeed, Frey et al.(129) recently presented a platform featuring high flexibility in arrangements and interconnections between microtissues for different”
BackgroundLiver cell models in in vitro toxicology.
Guillouzo, A. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.98106511 · Cited by 385 · cited 3×
“the historical perspective and advances that have been made in this field.(11,12,15,81,82) Briefly, the most popular culture configurations are ones in which confluent monolayers of primary hepatocytes are attached to adsorbed or gelled rat tail collagen I (widely and cheaply available) and then overlaid with another…”
BackgroundBogaards, J. J. P., Bertrand, M., Jackson, P., Oudshoorn, M. J., Weaver, R. J., Van Bladeren, P. J., & Walther, B. (2000) · Xenobiotica · doi:10.1080/00498250010021684 · Cited by 368 · cited 1×
“Moreover, comparisons of nine CYP450 enzymes in mouse, rat, rabbit, dog, micropig, and monkey liver microsomes to those derived from human livers revealed that, while no single species had enzyme activities close to human for all enzymes tested, different species could potentially be suitable for in vivo testing once…”
BackgroundOrganotypic liver culture models: meeting current challenges in toxicity testing
LeCluyse, E. L., Witek, R. P., Andersen, M. E., & Powers, M. J. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.682115 · Cited by 363 · cited 17×
“PHHs, isolated from the human liver via collagenase perfusion, are widely considered to be the “gold standard” for use in constructing liver models for drug testing and other life science applications.(11,12) A recent study showed that addition of an antioxidant, N-acetylcysteine, and replacement of collagenase with L…”
BackgroundMethodInfluentialHepatic stellate cells require a stiff environment for myofibroblastic differentiation
Olsen, A. L., Bloomer, S. A., Chan, E. P., Gaça, M. D. A., Georges, P. C., Sackey, B., Uemura, M., Janmey, P. A., & Wells, R. G. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00412.2010 · Cited by 355 · cited 1×
“HSCs develop a myofibroblast phenotype rapidly in vitro, which is a hallmark of liver fibrosis.(21,80) While modulating the compliance of a substrate has been shown to revert HSCs to a more quiescent state,(80) such substrates and techniques are not yet standard for drug screening applications.”
BackgroundToward engineering functional organ modules by additive manufacturing
Marga, F., Jakab, K., Khatiwala, C., Shepherd, B., Dorfman, S., Hubbard, B., Colbert, S., & Gabor, F. (2012) · Biofabrication · doi:10.1088/1758-5082/4/2/022001 · Cited by 348 · cited 1×
“Another promising strategy to create liver cell organoids is based on 3D bioprinting commercialized by Organovo (San Diego, CA).(130) One advantage of this technique is that printing in different locations can position different cell types relative to each other.”
BackgroundGuo, L., Dial, S., Shi, L., Branham, W., Liu, J., Fang, J.-L., Green, B., Deng, H., Kaput, J., & Ning, B. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035873 · Cited by 348 · cited 1×
“This conclusion is consistent with another study that evaluated HepG2 cells alongside Huh7, SK-Hep-1, Hep3B, and HepaRG cell lines and showed a complete absence or much lower abundance of certain drug metabolism enzymes and transporters in hepatic cell lines compared with multiple PHH donors.(37) Transfecting HepG2 ce…”
ResultCell Culture Models in Microfluidic Systems
Meyvantsson, I., & Beebe, D. J. (2008) · Annual Review of Analytical Chemistry · doi:10.1146/annurev.anchem.1.031207.113042 · Cited by 345 · cited 1×
“A variety of such micropatterning techniques are reviewed in other articles.(98,99) Briefly, photolithography allows patterning of photoresist (light-sensitive polymer) onto a silicon or glass wafer.”
BackgroundThe Role of Body-on-a-Chip Devices in Drug and Toxicity Studies
Esch, M. B., King, T. L., & Shuler, M. L. (2011) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071910-124629 · Cited by 328
Advances in bioartificial liver devices
Allen, J. W., Hassanein, T., & Bhatia, S. N. (2001) · Hepatology · doi:10.1053/jhep.2001.26753 · Cited by 326
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming
Du, Y., Wang, J., Jia, J., Song, N., Xiang, C., Xu, J., Hou, Z., Su, X., Liu, B., Jiang, T., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.01.008 · Cited by 320 · cited 1×
“Some more recent approaches include stimulation with small molecules that can reduce fetal markers in iHeps,(62) deriving iHeps from PHHs to maintain the native epigenetic modifications,(52) and direct lineage reprogramming of fibroblasts into iHeps using key hepatic fate and maturation transcription factors.(58,63) D…”
BackgroundMulti-cell type human liver microtissues for hepatotoxicity testing
Messner, S., Agarkova, I., Moritz, W., & Kelm, J. M. (2013) · Archives of Toxicology · doi:10.1007/s00204-012-0968-2 · Cited by 319 · cited 4×
“We also know that controlling the extent and placement of cell-cell interactions (both homotypic and heterotypic) in vitro either via micropatterning tools or via assembly of spheroids of controlled dimensions plays an important role in optimizing hepatocyte functions and enabling downstream applications that were pre…”
BackgroundInfluentialSivaraman, A., Leach, J., Townsend, S., Iida, T., Hogan, B., Stolz, D., Fry, R., Samson, L., Tannenbaum, S., & Griffith, L. (2005) · Current Drug Metabolism · doi:10.2174/138920005774832632 · Cited by 310 · cited 5×
“Twelve bioreactors have been engineered onto a single plate.(95,123) This platform is commercially available as LiverChip by CN Bio Innovations Limited (Oxfordshire, UK).”
BackgroundMethodInfluentialDevelopment of a Microscale Cell Culture Analog To Probe Naphthalene Toxicity
Viravaidya, K., Sin, A., & Shuler, M. L. (2008) · Biotechnology Progress · doi:10.1021/bp0341996 · Cited by 305
Li, A. P., Lu, C., Brent, J. A., Pham, C., Fackett, A., Ruegg, C. E., & Silber, P. M. (1999) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(99)00088-5 · Cited by 302 · cited 1×
“The use of cryopreserved PHHs affords several advantages that include convenient on-demand experimentation as opposed to the unpredictability in procurement of fresh cells; longitudinal studies in one donor, as opposed to significant interexperimental variability observed with the use of fresh PHHs from different dono…”
BackgroundCell Lines: A Tool for In Vitro Drug Metabolism Studies
Gomez-Lechon, M., Donato, M., Lahoz, A., & Castell, J. (2008) · Current Drug Metabolism · doi:10.2174/138920008783331086 · Cited by 300 · cited 1×
“Several hepatic cell lines have been used for drug development, including HepG2, HepaRG, Fa2N-4, and others.(8,33,34) While providing for a reproducible and nearly infinite source of liver cells for building initial iterations of engineered devices as well as for drug testing, cell lines are widely accepted to lack th…”
MethodChen, Y.-F., Tseng, C.-Y., Wang, H.-W., Kuo, H.-C., Yang, V. W., & Lee, O. K. (2012) · Hepatology · doi:10.1002/hep.24790 · Cited by 291
3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing
Takayama, K., Kawabata, K., Nagamoto, Y., Kishimoto, K., Tashiro, K., Sakurai, F., Tachibana, M., Kanda, K., Hayakawa, T., Furue, M. K., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.029 · Cited by 289 · cited 1×
“Culture of iHeps in spheroids has also been shown to improve their liver maturation.(124) Here, we will focus on spheroid technologies that have been developed for drug screening instead of bioartificial clinical devices.”
BackgroundCooperation of Liver Cells in Health and Disease
Kmieć, Z. (2001) · Advances in Anatomy Embryology and Cell Biology · doi:10.1007/978-3-642-56553-3 · Cited by 284 · cited 2×
“HSCs develop a myofibroblast phenotype rapidly in vitro, which is a hallmark of liver fibrosis.(21,80) While modulating the compliance of a substrate has been shown to revert HSCs to a more quiescent state,(80) such substrates and techniques are not yet standard for drug screening applications.”
BackgroundPluripotent stem cell-derived hepatocyte-like cells
Schwartz, R. E., Fleming, H. E., Khetani, S. R., & Bhatia, S. N. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.01.003 · Cited by 282 · cited 9×
“Evaluation of hepatotoxicity using multiparameter cell feature analysis measured by fluorescent imaging was implemented by O’Brien et al.181 using HepG2 and was later extended by Xu et al.180 to short-term ECM sandwich cultures of PHHs.”
BackgroundMethodInfluentialSelf-citationMaintenance of Human Hepatocyte Function In Vitro by Liver-Derived Extracellular Matrix Gels
Sellaro, T. L., Ranade, A., Faulk, D. M., McCabe, G. P., Dorko, K., Badylak, S. F., & Strom, S. C. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0587 · Cited by 276 · cited 1×
“Liver-inspired complex ECM mixtures and ECM derived directly from the liver have also been shown to induce key hepatic functions.(91,92) Finally, supplementation of culture medium with soluble factors, such as hormones (i.”
BackgroundMcGinnity, D. F., Soars, M. G., Urbanowicz, R. A., & Riley, R. J. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000026 · Cited by 274 · cited 1×
“For instance, cryopreserved PHHs stored in liquid nitrogen for more than 1 year showed no significant decrease in viability or activity upon thawing, when compared with the initial thaw, which was carried out within a week of cryopreservation.(70) Furthermore, the activity of thawed cryopreserved PHHs was on average 9…”
BackgroundFormation of steady‐state oxygen gradients in vitro: Application to liver zonation
Allen, J. W., & Bhatia, S. N. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10569 · Cited by 269 · cited 2×
“Such toxicity could be due to higher expression of CYP2B enzymes at the outlet, as shown in the Western blot.(138,139)”
BackgroundLiver-Specific Functional Studies in a Microfluidic Array of Primary Mammalian Hepatocytes
Kane, B. J., Zinner, M. J., Yarmush, M. L., & Toner, M. (2006) · Analytical Chemistry · doi:10.1021/ac051856v · Cited by 264 · cited 2×
“In another example, Kane et al.(149) developed an 8 × 8 element nonaddressable array of microfluidic wells capable of supporting micropatterned hepatocytefibroblast cocultures.”
MethodGripon, P., Diot, C., Thézé, N., Fourel, I., Loreal, O., Brechot, C., & Guguen-Guillouzo, C. (1988) · Journal of Virology · doi:10.1128/jvi.62.11.4136-4143.1988 · Cited by 262
Kostadinova, R., Boess, F., Applegate, D., Suter, L., Weiser, T., Singer, T., Naughton, B., & Roth, A. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.012 · Cited by 262 · cited 2×
“For example, in the RegeneMed (San Diego, CA) platform, liver NPCs (stellate cells, Kupffer macrophages, endothelia) are seeded onto a 3D porous nylon scaffold followed by seeding of hepatocytes (rat or human).(127) Human hepatic functions—in particular, secretion of albumin, fibrinogen, transferrin, and urea—were mai…”
BackgroundMethodInduced pluripotent stem cells: opportunities and challenges
Okita, K., & Yamanaka, S. (2011) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0016 · Cited by 261 · cited 1×
“In addition, iPSCs have been generated via the addition of fewer genes in certain cell types, small molecules, recombinant proteins, adenoviruses or Sendai viruses, messenger RNA (RNA), recombinant proteins, and transient expression plasmids.(48,49) Human iPSCs can mimic human ESCs in all aspects of pluripotency and c…”
BackgroundAndersson, T. B., Kanebratt, K. P., & Kenna, J. G. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.685159 · Cited by 259 · cited 1×
“The HepaRG cell line, which spontaneously differentiates in vitro into hepatocyte-like and cholangiocyte-like cells (representing the biliary epithelium of the liver), has emerged as a further differentiated and functional cell line relative to HepG2 and other cell lines.(39) In particular, their use in enzyme inducti…”
Shlomai, A., Schwartz, R. E., Ramanan, V., Bhatta, A., de Jong, Y. P., Bhatia, S. N., & Rice, C. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412631111 · Cited by 258 · cited 2×
“For HCV and HBV, the Bhatia group has also shown infection in cultures of iHeps, opening up avenues for studying the effects of donor genotype and host genes on infection efficiency, propagation, and resistance to drug therapies.(110,179) Despite impressive progress in the use of engineered MPCCs to enable sustained p…”
BackgroundMethodMouse liver repopulation with hepatocytes generated from human fibroblasts
Zhu, S., Rezvani, M., Harbell, J., Mattis, A. N., Wolfe, A. R., Benet, L. Z., Willenbring, H., & Ding, S. (2014) · Nature · doi:10.1038/nature13020 · Cited by 257
Identification of small molecules for human hepatocyte expansion and iPS differentiation
Shan, J., Schwartz, R. E., Ross, N. T., Logan, D. J., Thomas, D., Duncan, S. A., North, T. E., Goessling, W., Carpenter, A. E., & Bhatia, S. N. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1270 · Cited by 254
Generation of Endoderm-Derived Human Induced Pluripotent Stem Cells From Primary Hepatocytes
Liu, H., Ye, Z., Kim, Y., Sharkis, S., & Jang, Y.-Y. (2010) · Hepatology · doi:10.1002/hep.23626 · Cited by 250
Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective
Prueksaritanont, T., Chu, X., Gibson, C., Cui, D., Yee, K. L., Ballard, J., Cabalu, T., & Hochman, J. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9470-x · Cited by 248 · cited 2×
“The FDA has put forth a guidance document that lists the types of in vitro studies with human-relevant systems that can be performed to assess the potential for DDIs and allow companies to develop clinical trials to further probe the risks.(169) This is one area where conventional cultures of PHHs have made a tremendo…”
BackgroundHuman liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing
Tostões, R. M., Leite, S. B., Serra, M., Jensen, J., Björquist, P., Carrondo, M. J. T., Brito, C., & Alves, P. M. (2012) · Hepatology · doi:10.1002/hep.24760 · Cited by 246 · cited 2×
“Tostões et al.(141) recently used an automated perfusion bioreactor to maintain key functions and gene expression of PHH spheroids for a few weeks in culture, thereby providing an avenue to conduct repeated drug dosing.”
MethodGeneral Review on In Vitro Hepatocyte Models and Their Applications
Guguen-Guillouzo, C., & Guillouzo, A. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-688-7_1 · Cited by 239 · cited 1×
“We refer the readers to other review articles that discuss a plethora of these conventional techniques.(12,93) Here, we focus on those culture models that have been subjected to engineering tools, such as those adapted from the semiconductor industry and synthetic scaffolds for 3D tissue generation, to provide better…”
BackgroundBiochemical and Cellular Mechanisms of Toxic Liver Injury
Kaplowitz, N. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30100 · Cited by 239 · cited 5×
“Of such toxicities, drug-induced liver injury (DILI) is the most common cause of acute liver failures in the United States alone and is a leading cause of both the prelaunch and postmarket attrition of pharmaceuticals.4 For instance, DILI accounts for ~40% of the drugs that fail during clinical trials and has been lin…”
BackgroundInfluentialTakayama, K., Inamura, M., Kawabata, K., Katayama, K., Higuchi, M., Tashiro, K., Nonaka, A., Sakurai, F., Hayakawa, T., Kusuda Furue, M., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2011.234 · Cited by 235
In Vitro Zonation and Toxicity in a Hepatocyte Bioreactor
Allen, J. W. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi052 · Cited by 233 · cited 2×
“10).(139) In addition to creating gradients of molecular factors, bioreactors facilitate automated delivery of nutrients and other soluble factors to cultures as well as the removal of waste products.”
BackgroundLübberstedt, M., Müller-Vieira, U., Mayer, M., Biemel, K. M., Knöspel, F., Knobeloch, D., Nüssler, A. K., Gerlach, J. C., & Zeilinger, K. (2011) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.04.013 · Cited by 227 · cited 1×
“Another group showed that HepaRG could be used as a substitute for PHHs for evaluating drug clearance.(43) Although CYP450 activities between PHHs and HepaRG varied, clearance rates of select drugs were similar between the two models.”
ResultUse of Cryopreserved Human Hepatocytes in Sandwich Culture to Measure Hepatobiliary Transport
Bi, Y.-A., Kazolias, D., & Duignan, D. B. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.009118 · Cited by 216 · cited 1×
“This technique has been adapted to PHHs for use during drug development.(166) The technique established by Ghibellini et al.”
MethodACToR — Aggregated Computational Toxicology Resource
Judson, R., Richard, A., Dix, D., Houck, K., Elloumi, F., Martin, M., Cathey, T., Transue, T. R., Spencer, R., & Wolf, M. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.12.037 · Cited by 214 · cited 2×
“ACToR (Aggregated Computational Toxicology Resource) is a database software that contains information on chemical structures, in vitro bioassays, and in vivo toxicology assays derived from >150 sources such as the U.S. Environmental Protection Agency (EPA), Centers for Disease Control and Prevention (CDC), the World H…”
BackgroundThompson, R. A., Isin, E. M., Li, Y., Weidolf, L., Page, K., Wilson, I., Swallow, S., Middleton, B., Stahl, S., Foster, A. J., et al. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300091x · Cited by 213
Kidambi, S., Yarmush, R. S., Novik, E., Chao, P., Yarmush, M. L., & Nahmias, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906820106 · Cited by 213 · cited 1×
“Since PHHs are highly metabolically active, their oxygen uptake through the culture medium has been shown to be important in the rate at which they recover in vitro to higher functional levels following the trauma of isolation.(200) Thus, optimizing a given media formulation (including oxygen diffusion through the med…”
BackgroundModeling hepatitis C virus infection using human induced pluripotent stem cells
Schwartz, R. E., Trehan, K., Andrus, L., Sheahan, T. P., Ploss, A., Duncan, S. A., Rice, C. M., & Bhatia, S. N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121400109 · Cited by 213 · cited 1×
“For HCV and HBV, the Bhatia group has also shown infection in cultures of iHeps, opening up avenues for studying the effects of donor genotype and host genes on infection efficiency, propagation, and resistance to drug therapies.(110,179) Despite impressive progress in the use of engineered MPCCs to enable sustained p…”
BackgroundMarch, S., Ng, S., Velmurugan, S., Galstian, A., Shan, J., Logan, D. J., Carpenter, A. E., Thomas, D., Sim, B. K. L., Mota, M. M., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.06.005 · Cited by 212
A microfluidic hepatic coculture platform for cell-based drug metabolism studies
Novik, E., Maguire, T. J., Chao, P., Cheng, K. C., & Yarmush, M. L. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.11.010 · Cited by 212 · cited 5×
“Yet, even in 2D monolayers directly exposed to flowing fluid, Novik et al.(148) showed that flow-based cocultures of PHHs and endothelial cells were able to better predict in vivo drug clearance and produce drug Figure 10.”
BackgroundInfluentialPhenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms
Kleinstreuer, N. C., Yang, J., Berg, E. L., Knudsen, T. B., Richard, A. M., Martin, M. T., Reif, D. M., Judson, R. S., Polokoff, M., Dix, D. J., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2914 · Cited by 211 · cited 1×
“For instance, the ToxCast project by the EPA is evaluating diverse in vitro assays for understanding different types of molecular and pathway perturbations caused by environmental chemicals and pharmaceuticals to build initial prioritization models of in vivo toxicity.(193) Chemical-response signatures for 87 end poin…”
BackgroundPersistent hepatitis C virus infection in microscale primary human hepatocyte cultures
Ploss, A., Khetani, S. R., Jones, C. T., Syder, A. J., Trehan, K., Gaysinskaya, V. A., Mu, K., Ritola, K., Rice, C. M., & Bhatia, S. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915130107 · Cited by 211 · cited 2×
“Dose-dependent inhibition of HCVcc replication in MPCCs treated with interferon (IFN)–α or various drugs against viral proteins (B).(108)”
BackgroundMethodSelf-citationUse of Micropatterned Cocultures to Detect Compounds That Cause Drug-Induced Liver Injury in Humans
Khetani, S. R., Kanchagar, C., Ukairo, O., Krzyzewski, S., Moore, A., Shi, J., Aoyama, S., Aleo, M., & Will, Y. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kfs326 · Cited by 208 · cited 6×
“We have shown that when MPCCs created with PHHs were subjected to repeat drug doses over 9 days (4 total dose administrations), the sensitivity of drug toxicity detection improved to 70% to 75% (without compromising specificity of the assay) compared to ~30% sensitivity in sandwich cultures created from the same PHH d…”
BackgroundMethodInfluentialSelf-citationAssessment of hepatocellular function within PEG hydrogels
Underhill, G. H., Chen, A. A., Albrecht, D. R., & Bhatia, S. N. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.08.043 · Cited by 206 · cited 1×
“In the case of the liver, the Bhatia group has cultured primary hepatocytes and supportive NPCs (fibroblasts, endothelia) in PEG hydrogels containing the RGD (arginineglycine-aspartic acid) peptide to ligate hepatocyte surface integrins and enable long-term survival and functions.(133,134) In addition, patterned photo…”
MethodTsuda, Y., Kikuchi, A., Yamato, M., Nakao, A., Sakurai, Y., Umezu, M., & Okano, T. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.06.005 · Cited by 194 · cited 1×
“Thermo-responsive substrates have also been used to create micropatterned cocultures with better control over placement and subsequent removal of specific cell types.(117,118) However, such “dynamic” cell culture substrates lead to a reduction in throughput for drug testing, and specific training of personnel on handl…”
MethodLe Vee, M., Jigorel, E., Glaise, D., Gripon, P., Guguen-Guillouzo, C., & Fardel, O. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.01.004 · Cited by 190 · cited 2×
“Le Vee et al.(40,41) showed that HepaRG have key sinusoidal and canalicular membrane transporters at both the transcript and functional levels, whereas HepG2 cells showed notable expression of fewer transporters.”
BackgroundDalvie, D., Obach, R. S., Kang, P., Prakash, C., Loi, C.-M., Hurst, S., Nedderman, A., Goulet, L., Smith, E., Bu, H.-Z., et al. (2009) · Chemical Research in Toxicology · doi:10.1021/tx8004357 · Cited by 188 · cited 2×
“, ECM sandwich) have underperformed with ~30% to 50% prediction of clinical outcomes.(8,162,180) We now know that stabilizing the PHH phenotype using contact coculture with NPCs, even non–liver derived (i.”
BackgroundCutting the cost of drug development?
Rawlins, M. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1347 · Cited by 187
Kulig, K. M., & Vacanti, J. P. (2004) · Transplant Immunology · doi:10.1016/j.trim.2003.12.005 · Cited by 187
Idiosyncratic drug-induced liver injury: an overview
Hussaini, S. H., & Farrington, E. A. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.6.673 · Cited by 183 · cited 5×
“Of such toxicities, drug-induced liver injury (DILI) is the most common cause of acute liver failures in the United States alone and is a leading cause of both the prelaunch and postmarket attrition of pharmaceuticals.4 For instance, DILI accounts for ~40% of the drugs that fail during clinical trials and has been lin…”
BackgroundInfluentialIntegrating biological vasculature into a multi-organ-chip microsystem
Schimek, K., Busek, M., Brincker, S., Groth, B., Hoffmann, S., Lauster, R., Lindner, G., Lorenz, A., Menzel, U., Sonntag, F., et al. (2013) · Lab on a Chip · doi:10.1039/c3lc50217a · Cited by 180 · cited 1×
“In another cell-based approach, Schimek et al.(202) coat their microchannels with primary human dermal microvascular endothelial cells, thereby preventing drug-related material from binding to the plastic.”
BackgroundHarrill, A. H., Watkins, P. B., Su, S., Ross, P. K., Harbourt, D. E., Stylianou, I. M., Boorman, G. A., Russo, M. W., Sackler, R. S., Harris, S. C., et al. (2009) · Genome Research · doi:10.1101/gr.090241.108 · Cited by 177 · cited 1×
“, mice).(22) Thus, with the goal of reducing and refining studies in animals and to compare drug responses with human liver cells, building in vitro liver models using hepatocytes from different animal species is currently a worthwhile endeavor.”
BackgroundGripon, P., Diot, C., & Guguen-Guillouzo, C. (1993) · Virology · doi:10.1006/viro.1993.1069 · Cited by 166
Microenvironmental regulation of the sinusoidal endothelial cell phenotype in vitro #
March, S., Hui, E. E., Underhill, G. H., Khetani, S., & Bhatia, S. N. (2009) · Hepatology · doi:10.1002/hep.23085 · Cited by 164 · cited 5×
“Furthermore, there is evidence that coculture of different liver cell types in the same device/ well allows better stability and functionality of each cell type as opposed to when they are cultured alone.(79,95,121) However, while this “coculture effect” appears to be well conserved across species, not all NPCs induce…”
BackgroundResultInfluentialSelf-citationIntegration of Technologies for Hepatic Tissue Engineering
Nahmias, Y., Berthiaume, F., & Yarmush, M. L. (2006) · Springer eBooks · doi:10.1007/10_029 · Cited by 163 · cited 1×
“No current system can provide both compartments, although some designs have been proposed.(167) It is possible that coculture with cholangiocytes (cells that form small biliary ductules) in vitro may provide clues as to how these cells interface with hepatic bile canaliculi to drain the biliary contents in vivo.”
BackgroundLee, M.-Y., Park, C. B., Dordick, J. S., & Clark, D. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406755102 · Cited by 163 · cited 1×
“More recent research has focused on creating miniaturized arrays of spotted enzymes in gels to make the screening process higher throughput.(16) However, cell-free microsomes and other purified enzymatic systems lack the dynamic gene expression and cellular machinery required to be useful for drug toxicity and drug ef…”
Chao, P., Maguire, T., Novik, E., Cheng, K.-C., & Yarmush, M. L. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.013 · Cited by 161
Chan, T. S., Yu, H., Moore, A., Khetani, S. R., & Tweedie, D. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.053397 · Cited by 160
Self-citationChimeric Mice with Humanized Liver: Tools for the Study of Drug Metabolism, Excretion, and Toxicity
Strom, S. C., Davila, J., & Grompe, M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-688-7_27 · Cited by 159
Liver tissue engineering in the evaluation of drug safety
Dash, A., Inman, W., Hoffmaster, K., Sevidal, S., Kelly, J., Obach, R. S., Griffith, L. G., & Tannenbaum, S. R. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903160664 · Cited by 158 · cited 6×
“Twelve bioreactors have been engineered onto a single plate.(95,123) This platform is commercially available as LiverChip by CN Bio Innovations Limited (Oxfordshire, UK).”
BackgroundMethodInfluentialIsolation and Culture of Primary Human Hepatocytes
LeCluyse, E. L., Alexandre, E., Hamilton, G. A., Viollon-Abadie, C., Coon, D. J., Jolley, S., & Richert, L. (2004) · Basic Cell Culture Protocols · doi:10.1385/1-59259-838-2:207 · Cited by 157 · cited 1×
“Moreover, PHHs from liver biopsies extracted from living patients can provide a more viable source of PHHs than tissues from deceased and beating-heart donors.(67) Advances in cryopreservation methodologies have greatly facilitated the commercial availability of characterized PHH donor lots from several different vend…”
BackgroundWang, W. W., Khetani, S. R., Krzyzewski, S., Duignan, D. B., & Obach, R. S. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.034876 · Cited by 157 · cited 10×
“For such reasons, ~50% of clinically relevant major drug metabolites are missed in conventional model systems.(106,162) For secondary metabolites, which are typically several reactions from the parent molecule and may take some time to generate, the miss rate increases to ~62% (38% identification rate).”
BackgroundMethodInfluentialSelf-citationBioartificial liver systems: current status and future perspective
Park, J.-K., & Lee, D. (2005) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.99.311 · Cited by 155
Humanized mice with ectopic artificial liver tissues
Chen, A. A., Thomas, D. K., Ong, L. L., Schwartz, R. E., Golub, T. R., & Bhatia, S. N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101791108 · Cited by 155 · cited 1×
“, intraperitoneal), leaving the rodent liver fully intact.(32) Human-relevant drug metabolites generated via the PHHs implanted in rodent livers could generate toxicity in another organ, thereby allowing assessment of safety of such metabolites.”
BackgroundPhysiologically relevant organs on chips
Yum, K., Hong, S. G., Healy, K. E., & Lee, L. P. (2014) · Biotechnology Journal · doi:10.1002/biot.201300187 · Cited by 150
Tweedie, D., Polli, J. W., Berglund, E. G., Huang, S. M., Zhang, L., Poirier, A., Chu, X., & Feng, B. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.77 · Cited by 146
Evolving concepts in liver tissue modeling and implications for in vitro toxicology
Guillouzo, A., & Guguen-Guillouzo, C. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.10.1279 · Cited by 145 · cited 1×
“Culture media formulation has also proven to be critical in inducing higher functions and longevity of hepatocyte culture models.(11,81,199) Furthermore, optimal media formulations can vary considerably depending on the types of NPCs used alongside PHHs.”
BackgroundEngineering tissues for in vitro applications
Khetani, S. R., & Bhatia, S. N. (2006) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2006.08.009 · Cited by 141 · cited 1×
“Microfabrication tools have been used extensively to investigate biological phenomena in different model systems.(98,100) In the case of the liver, Singhvi et al.”
MethodSelf-citationIn vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus.
Fournier, C., Pageaux, G., Maurel, P., Coste, J., Larrey, D. G., Ducos, J., Sureau, C., & Domergue, J. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-10-2367 · Cited by 141
Cosgrove, B. D., King, B. M., Hasan, M. A., Alexopoulos, L. G., Farazi, P. A., Hendriks, B. S., Griffith, L. G., Sorger, P. K., Tidor, B., Xu, J. J., et al. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.04.002 · Cited by 136 · cited 1×
“Trovafloxacin toxicity, in particular, was sensitive to lipopolysaccharide (LPS)–mediated stimulation of Kupffer macrophages, a finding consistent with other studies in 2D monolayers.(128) While the consistency in size distribution of the microtissues is impressive (i.”
ResultBhogal, R. H., Hodson, J., Bartlett, D. C., Weston, C. J., Curbishley, S. M., Haughton, E., Williams, K. T., Reynolds, G. M., Newsome, P. N., Adams, D. H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018222 · Cited by 136 · cited 1×
“PHHs have also been isolated from fibrotic and fatty livers, providing the ability to compare cells with a history of disease to control cells that do not display that particular disease phenotype.(66) Moreover, PHHs from liver biopsies extracted from living patients can provide a more viable source of PHHs than tissu…”
BackgroundRichert, L., Liguori, M. J., Abadie, C., Heyd, B., Mantion, G., Halkic, N., & Waring, J. F. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007708 · Cited by 136 · cited 1×
“Characterization using gene expression profiling showed that isolation and cryopreservation did not significantly impair PHH gene expression relative to native liver tissue.(69) Functional characterization of fresh and cryopreserved PHHs from the same donors using prototypical drugs has also revealed significant simil…”
BackgroundLi, C. Y., Stevens, K. R., Schwartz, R. E., Alejandro, B. S., Huang, J. H., & Bhatia, S. N. (2014) · Tissue Engineering Part A · doi:10.1089/ten.tea.2013.0667 · Cited by 132 · cited 3×
“The process of panel B can be done simultaneously in all wells of a 96-well plate, yielding hepatocyte islands (primary human hepatocytes [PHHs] shown here) surrounded by 3T3-J2 murine embryonic fibroblasts (C).(74,105) This platform is commercially available as HepatoPac by Hepregen Corporation (Medford, MA).”
MethodGoral, V. N., Hsieh, Y.-C., Petzold, O. N., Clark, J. S., Yuen, P. K., & Faris, R. A. (2010) · Lab on a Chip · doi:10.1039/c0lc00135j · Cited by 130 · cited 2×
“Goral et al.144 devised a microfluidic device that promotes the 3D organization of hepatocytes into cord-like structures (as in vivo) without the addition of biological or synthetic matrices.”
BackgroundKim, Y., & Rajagopalan, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015456 · Cited by 125
Khetani, S. R., Szulgit, G., Del Rio, J. A., Barlow, C., & Bhatia, S. N. (2004) · Hepatology · doi:10.1002/hep.20351 · Cited by 123 · cited 3×
“These studies revealed that cell-cell contact played a critical role in modulating hepatocyte functions by several fold, likely due to cadherin interactions as observed in other studies.81 As in studies by Guguen-Guillouzo et al,102 physical contact with stromal cells (i.e., fibroblasts) was required in MPCCs to signi…”
BackgroundSelf-citationHigh-Content Assays for Hepatotoxicity Using Induced Pluripotent Stem Cell–Derived Cells
Sirenko, O., Hesley, J., Rusyn, I., & Cromwell, E. F. (2014) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2013.520 · Cited by 123 · cited 1×
“More recently, HCS has been adapted to monolayers of iHeps, although comparisons to PHHs were lacking.(182) CellCiphr Profiling by Cellumen (now offered by Cyprotex, Watertown, MA) was the first commercial assay introduced in 2007 to predict hepatotoxicity using multiparameter HCS-based fluorescent probe measurements.”
A Novel Relay Method for Determining Low-Clearance Values
Di, L., Trapa, P. E., Obach, R. S., Atkinson, K. A., Bi, Y., Wolford, A. C., Tan, B., McDonald, T. S., Lai, Y., & Tremaine, L. M. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.046425 · Cited by 123 · cited 1×
“, drug incubated across multiple thawed cell vials) to obtain enough turnover of low-clearance compounds to be able to predict in vivo clearance.(160) However, selection of specific pooled cryopreserved PHH lots and banking for future use are important for this method, as not every lot will work well with this strateg…”
MethodScavenger Receptor BI Boosts Hepatocyte Permissiveness to Plasmodium Infection
Yalaoui, S., Huby, T., Franetich, J., Gego, A., Rametti‐Lacroux, A., Moreau, M., Collet, X., Siau, A., van Gemert, G., Sauerwein, R. W., et al. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.07.013 · Cited by 122
Kirby, B. J., Collier, A. C., Kharasch, E. D., Whittington, D., Thummel, K. E., & Unadkat, J. D. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.037523 · Cited by 121 · cited 1×
“There have been several cases of DDIs in the clinic, and now warnings on drug labels for such interactions are common.(168,169) In many cases, DDIs occur via drug-mediated induction or inhibition of CYP450 enzyme activities.”
BackgroundPolarized expression of drug transporters in differentiated human hepatoma HepaRG cells
Vée, M. L., Noel, G. L., Jouan, E., Stieger, B., & Fardel, O. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.07.003 · Cited by 120 · cited 2×
“Le Vee et al.(40,41) showed that HepaRG have key sinusoidal and canalicular membrane transporters at both the transcript and functional levels, whereas HepG2 cells showed notable expression of fewer transporters.”
BackgroundMetabolic activation in drug-induced liver injury
Leung, L., Kalgutkar, A. S., & Obach, R. S. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.605791 · Cited by 118 · cited 1×
“Although phase I and II metabolism in the liver is typically referred to as “metabolic detoxification,” many xenobiotics are metabolized into pharmacologically active or toxic compounds.(14) In phase III of drug disposition, highly polar metabolites are transported out of hepatocytes via transporters into the bile thr…”
BackgroundLayered Patterning of Hepatocytes in Co-Culture Systems using Microfabricated Stencils
Cho, C. H., Park, J., Tilles, A. W., Berthiaume, F., Toner, M., & Yarmush, M. L. (2010) · BioTechniques · doi:10.2144/000113317 · Cited by 116 · cited 1×
“, layered) and compare functions with the coplanar configuration.(112) The authors found that increasing the hepatocyte-fibroblast interactions via layering improved several liver functions and allowed more uniform albumin staining in the entire hepatocyte island than in the coplanar configuration.”
BackgroundLiver-Based In Vitro Technologies for Drug Biotransformation Studies - A Review
Fasinu, P. S., Bouic, P. J., & Rosenkranz, B. (2012) · Current Drug Metabolism · doi:10.2174/138920012798918426 · Cited by 115
In Vitro–In Vivo Correlation of Hepatobiliary Drug Clearance in Humans
Ghibellini, G., Vasist, L. S., Leslie, E. M., Heizer, W. D., Kowalsky, R. J., Calvo, B. F., & Brouwer, K. L. R. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100059 · Cited by 114
Approaching the in vitro clinical trial: engineering organs on chips
Capulli, A. K., Tian, K., Mehandru, N., Bukhta, A., Choudhury, S. F., Suchyta, M., & Parker, K. K. (2014) · Lab on a Chip · doi:10.1039/c4lc00276h · Cited by 111
Nagamoto, Y., Tashiro, K., Takayama, K., Ohashi, K., Kawabata, K., Sakurai, F., Tachibana, M., Hayakawa, T., Furue, M. K., & Mizuguchi, H. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.011 · Cited by 110 · cited 1×
“More recently, a handful of groups have tested this so-called coculture effect on iHeps using non–liver NPCs such as murine embryonic Swiss-3T3 fibroblasts as well as a combination of MSCs (mesenchymal stem cells) and HUVECs (human umbilical vein endothelial cells).(89,90) Liver-inspired complex ECM mixtures and ECM d…”
BackgroundIdiosyncratic Toxicity: A Convergence of Risk Factors
Ulrich, R. G. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.072905.160823 · Cited by 109 · cited 1×
“However, it is known that risk factors in human patients include disease, sex, age, comedications, nutritional status, innate immune system activation, physical activity, and genetic predisposition.(10) Thus, there are increasing pressures on regulatory agencies and the pharmaceutical industry to find more effective w…”
BackgroundSinusoidal endothelial cells as a target for acetaminophen toxicity
DeLeve, L. D., Wang, X., Kaplowitz, N., Shulman, H. M., Bart, J. A., & Hoek, A. V. D. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00048-8 · Cited by 108
Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro
Dash, A., Simmers, M. B., Deering, T. G., Berry, D. J., Feaver, R. E., Hastings, N. E., Pruett, T. L., LeCluyse, E. L., Blackman, B. R., & Wamhoff, B. R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00331.2012 · Cited by 108 · cited 2×
“Dash et al.147 adapted a commercially available (HemoShear, Charlottesville, VA) cone and plate technology (previously used for subjecting smooth muscle cell and endothelial cell cocultures to physiological hemodynamics to restore vascular phenotype) to rat hepatocytes cultured in the aforementioned collagen gel sandw…”
MethodHowell, B. A., Yang, Y., Kumar, R., Woodhead, J. L., Harrill, A. H., M.A., H. J. C. I., Andersen, M. E., Siler, S. Q., & Watkins, P. B. (2012) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-012-9266-0 · Cited by 107
Rumin, S., Berthillon, P., Tanaka, E., Kiyosawa, K., Trabaud, M., Bizollon, T., Gouillat, C., Gripon, P., Guguen‐Guillouzo, C., Inchauspé, G., et al. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-11-3007 · Cited by 107
The application of 3D cell models to support drug safety assessment: Opportunities & challenges
Roth, A. B., & Singer, T. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.005 · Cited by 105 · cited 3×
“Whole-genome microarray analysis revealed that after ~4 weeks, the model did not resemble an in vivo liver at least at the gene expression level, even though some hepatic functional markers were found to be stable past 4 weeks.(120) This type of result underscores the critical need to extensively characterize and vali…”
BackgroundHegde, M., Jindal, R., Bhushan, A., Bale, S. S., McCarty, W. J., Golberg, I., Usta, O. B., & Yarmush, M. L. (2014) · Lab Chip · doi:10.1039/c4lc00071d · Cited by 104 · cited 2×
“More recently, Hegde et al.(146) designed a microfluidic device with a porous membrane sandwiched between two chambers of PDMS.”
BackgroundAntiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection
Tennant, B. C., Baldwin, B. H., Graham, L. A., Ascenzi, M., Hornbuckle, W. E., Rowland, P. H., Tochkov, I. A., Yeager, A. E., Erb, H. N., Colacino, J. M., et al. (1998) · Hepatology · doi:10.1002/hep.510280124 · Cited by 103 · cited 1×
“In another instance of defining relevance between humans and animals for behavior of specific drug classes, the woodchuck has been shown to be a better model for chronic human-like hepatitis infection and disease progression than other species and thus was used to study the antiviral activity and toxicity of fialuridi…”
BackgroundHariparsad, N., Carr, B., Evers, R., & Chu, X. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.020677 · Cited by 102 · cited 2×
“Furthermore, Fa2N-4 cells were lacking an important nuclear receptor (constitutive androstane receptor or CAR), which limits the utility of these cells for drug-mediated enzyme induction studies to predict drug-drug interaction potential.(34) The reported sensitivities and specificities of cell lines for accurate dete…”
BackgroundMethodKupffer cell-mediated differential down-regulation of cytochrome P450 metabolism in rat hepatocytes
Milosevic, N., Schawalder, H. P., & Maier, P. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00988-1 · Cited by 100
Atypical causes of cholestasis
Nguyen, K. D., Sundaram, V., & Ayoub, W. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i28.9418 · Cited by 99 · cited 4×
“Bhatia et al.96 then extended the aforementioned patterning to micropatterned coculture (MPCC) of rat hepatocytes with supportive NPCs.”
BackgroundInfluentialLiu, Z., Shi, Q., Ding, D., Kelly, R., Fang, H., & Tong, W. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002310 · Cited by 96 · cited 2×
“Promising results for DILI prediction have been demonstrated in a few cases, such as improved prediction over animal models using short-term drug dosing in sandwich cultures of PHHs coupled with a high-content imaging classifier(180) and an in silico SAR model that relates chemical structures to the liver side effect…”
BackgroundPREDICTION OF DRUG-DRUG INTERACTIONS FROM IN VITRO INDUCTION DATA
Fahmi, O. A., Boldt, S. E., Kish, M., Obach, R. S., & Tremaine, L. M. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021907 · Cited by 95 · cited 1×
“Overall, mRNA transcript assessment has been shown to be a more sensitive measure of induction, rather than enzyme activity.(170) While the aforesaid protocols for use of PHHs in predicting DDIs constitute an advance for in vitro human-relevant liver models during drug development, there are some key limitations.”
BackgroundLiu, Y., Li, H., Yan, S., Wei, J., & Li, X. (2014) · Biomacromolecules · doi:10.1021/bm401926k · Cited by 94 · cited 2×
“For instance, spheroids of rat hepatocytes can be created by seeding cells into 24-well plates (microspace cell culture plate; Kuraray Co, Tokyo, Japan) having a specific spheroid-forming microarchitecture at the bottom of each well (grids of specific depth).125 Another type of 96-well plate, available as Cell-able, (…”
BackgroundDriessen, M., Kienhuis, A. S., Pennings, J. L. A., Pronk, T. E., van den Brandhof, E., Roodbergen, M., Spaink, H. P., van de Water, B., & van der Ven, L. T. M. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1039-z · Cited by 93 · cited 1×
“Some interesting developments in the use of nonhuman species for drug testing have been zebrafish whole embryos for testing the potential toxicity of new pharmaceuticals.(29) This model allows for the use of a whole organism with multiple organs present to evaluate the effects of drugs in a high-throughput format.”
BackgroundSpecies differences in hepatocyte induction of CYP1A1 and CYP1A2 by omeprazole
Shih, H., Pickwell, G. V., Guenette, D. K., Bilir, B., & Quattrochi, L. C. (1999) · Human & Experimental Toxicology · doi:10.1177/096032719901800206 · Cited by 92 · cited 1×
“Thus, with the goal of reducing and refining studies in animals and to compare drug responses with human liver cells, building in vitro liver models using hepatocytes from different animal species is currently a worthwhile endeavor.(7,23,24) Indeed, animal hepatocytes (i.”
BackgroundHepatitis C Virus Replication in Transfected and Serum-Infected Cultured Human Fetal Hepatocytes
Lázaro, C. A., Chang, M., Tang, W., Campbell, J. S., Sullivan, D. G., Gretch, D. R., Corey, L., Coombs, R. W., & Fausto, N. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060789 · Cited by 91
Tolosa, L., Gómez‐Lechón, M. J., Pérez-Cataldo, G., Castell, J. V., & Donato, M. T. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1012-x · Cited by 91 · cited 1×
“Transfecting HepG2 cells with an adenovirus expressing the major CYP450 enzymes involved in drug metabolism resulted in lower IC50 values of bioactivated compounds compared with dosing in untransfected controls.(38) However, drug metabolism and toxicity are often very complex, involving multiple enzymatic processes; t…”
BackgroundChimeric mice with humanized liver
Katoh, M., Tateno, C., Yoshizato, K., & Yokoi, T. (2007) · Toxicology · doi:10.1016/j.tox.2007.11.012 · Cited by 91
Hepatocyte and Kupffer Cells Co-cultured on Micropatterned Surfaces to Optimize Hepatocyte Function
Zinchenko, Y. S., Schrum, L. W., Clemens, M., & Coger, R. N. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.751 · Cited by 89 · cited 2×
“For instance, Zinchenko et al.111 created micropatterned cocultures of rat hepatocytes with Kupffer macrophages using both photolithographic and soft lithographic (stencils) techniques and found better liver functions for 10 days in culture.”
Chen, A. A., Khetani, S. R., Lee, S., Bhatia, S. N., & Van Vliet, K. J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.10.055 · Cited by 88 · cited 1×
“Culture of hepatocytes into self-assembled 3D spheroids/ aggregates has been carried out extensively on nonadhesive surfaces or ones that are highly compliant such that hepatocytes cannot fully spread out.(12,87,122,123) The simplest examples of such models are to culture spontaneously forming hepatocyte aggregates on…”
BackgroundSelf-citationHighly Efficient Differentiation of Functional Hepatocytes From Human Induced Pluripotent Stem Cells
Ma, X., Duan, Y., Tschudy-Seney, B., Roll, G., Behbahan, I. S., Ahuja, T. P., Tolstikov, V., Wang, C., McGee, J., Khoobyari, S., et al. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0160 · Cited by 87
The Liver Toxicity Knowledge Base: A Systems Approach to a Complex End Point
Chen, M., Zhang, J., Wang, Y., Liu, Z., Kelly, R., Zhou, G., Fang, H., Borlak, J., & Tong, W. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.16 · Cited by 87
Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes
Lauer, B., Tuschl, G., Kling, M., & Mueller, S. O. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.10.031 · Cited by 83
Endothelium-Mediated Hepatocyte Recruitment in the Establishment of Liver-like Tissue In Vitro
Nahmias, Y., Schwartz, R. E., Hu, W.-S., Verfaillie, C. M., & Odde, D. J. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.1627 · Cited by 80 · cited 4×
“Nahmias et al.(113) showed that hepatocytes migrated toward and adhered to endothelial vascular structures formed on Matrigel.”
BackgroundMethodInfluentialEU Framework 6 Project: Predictive Toxicology (PredTox)—overview and outcome
Suter‐Dick, L., Schroeder, S., Meyer, K., Gautier, J., Amberg, A., Wendt, M., Gmuender, H., Mally, A., Boitier, E., Ellinger-Ziegelbauer, H. C., et al. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.10.008 · Cited by 79 · cited 1×
“Furthermore, proteomics and metabolomics were limited to being supportive of the findings at the transcriptomic level.(188) Thus, the use of tissue transcriptomics still needs to be coupled with histopathology to deliver the best results.”
BackgroundBuck, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002660 · Cited by 77
Shoda, L. K. M., Woodhead, J. L., Siler, S. Q., Watkins, P. B., & Howell, B. A. (2014) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1878 · Cited by 75 · cited 1×
“For instance, DILIsym software simulates the mechanistic interactions and events from drug administration through the progression of liver injury and regeneration.(196) This software can model some aspects of mitochondrial toxicity, bile acid toxicity, and innate immune responses.”
MethodRamsden, D., Tweedie, D., Chan, T. S., Taub, M. E., & Li, Y. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.055897 · Cited by 74
STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer
Nguyen, A. V., Wu, Y.-Y., & Lin, E. Y. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i30.10279 · Cited by 73
Evaluation of Human Hepatocytes Cultured by Three-dimensional Spheroid Systems for Drug Metabolism
Ohkura, T., Ohta, K., Nagao, T., Kusumoto, K., Koeda, A., Ueda, T., Jomura, T., Ikeya, T., Ozeki, E., Wada, K., et al. (2014) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-13-rg-105 · Cited by 71 · cited 2×
“, Carlsbad, CA) allows semisphere-shaped and uniformsized hepatocyte spheroids to form on ECM-coated adhesive domains surrounded by a nonadhesive coating, which are patterned using photolithography.(87) Liu et al.”
BackgroundToxicogenomics in Drug Development
Guerreiro, N., Staedtler, F., Grenet, O., Kehren, J., & Chibout, S. (2003) · Toxicologic Pathology · doi:10.1080/01926230390224656 · Cited by 69 · cited 2×
“The majority of TGx studies have been performed in rats.(185,186) However, while the proof of concept has been established for the value of TGx in preclinical drug development, the sensitivity of DILI predictions between rats and humans has not been adequate, presumably due to the species-specific differences in drug…”
BackgroundLaminar-flow immediate-overlay hepatocyte sandwich perfusion system for drug hepatotoxicity testing
Xia, L., Ng, S., Han, R., Tuo, X., Xiao, G., Leo, H. L., Cheng, T., & Yu, H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.022 · Cited by 67 · cited 2×
“Xia et al.145 have designed a flow bioreactor out of acrylic and an oxygenpermeable, collagen-coated porous membrane to protect rat hepatocytes from the impact of fluid flow.”
BackgroundRobison, T. W., & Jacobs, A. C. (2009) · Bioanalysis · doi:10.4155/bio.09.98 · Cited by 66
Szabo, M., Veres, Z., Baranyai, Z., Jakab, F., & Jemnitz, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059432 · Cited by 65 · cited 2×
“Szabo et al.42 further showed that HepaRG could serve as a good model for evaluating the effects of drugs on the uptake of probe substrates and the potential for downstream cholestasis.”
BackgroundHuman Induced Pluripotent Stem Cells in Hepatology
Gerbal-Chaloin, S., Funakoshi, N., Caillaud, A., Gondeau, C., Champon, B., & Si-Tayeb, K. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.09.026 · Cited by 64 · cited 9×
“Evaluation of hepatotoxicity using multiparameter cell feature analysis measured by fluorescent imaging was implemented by O’Brien et al.181 using HepG2 and was later extended by Xu et al.180 to short-term ECM sandwich cultures of PHHs.”
BackgroundMethodInfluentialTethered spheroids as an in vitro hepatocyte model for drug safety screening
Xia, L., Sakban, R. B., Qu, Y., Hong, X., Zhang, W., Nugraha, B., Tong, W. H., Ananthanarayanan, A., Zheng, B., Chau, I. Y.-Y., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.006 · Cited by 63
Terry, C., Dhawan, A., Mitry, R. R., Lehec, S. C., & Hughes, R. D. (2006) · Liver Transplantation · doi:10.1002/lt.20683 · Cited by 62
Long‐Term Stability of Primary Rat Hepatocytes in Micropatterned Cocultures
Ukairo, O., Kanchagar, C., Moore, A., Shi, J., Gaffney, J., Aoyama, S., Rose, K., Krzyzewski, S., McGeehan, J., Andersen, M. E., et al. (2013) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21469 · Cited by 61 · cited 3×
“Such circular architecture has been found to remain intact with respect to the fidelity of patterning, hepatic morphology, gene expression, and liver functions for 4 to 6 weeks for PHHs(74) and up to 10 weeks for rat hepatocytes.(24) MPCCs have been extensively validated for use in predictive drug testing.”
BackgroundSelf-citationZhang, M., Chen, M., & Tong, W. (2012) · Chemical Research in Toxicology · doi:10.1021/tx200320e · Cited by 58 · cited 1×
“For instance, an FDA study found that the DILI potential of a drug on humans can only be reasonably assessed using TGx analyses of in vivo studies in rats if the drug produced significant elevation of alanine aminotransferase (ALT) or total bilirubin (TBL).(187) But when ALT or TBL levels were not elevated in vivo, th…”
BackgroundAtienzar, F., Novik, E., Gerets, H. H. J., Parekh, A., Delatour, C., Cardenas, A., MacDonald, J. S., Yarmush, M. L., & Dhalluin, S. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.11.022 · Cited by 58 · cited 2×
“For instance, Atienzar et al.(36) reported a sensitivity of 80% for HepG2 cells using 40 known liver toxic drugs but a low specificity of 40% (i.”
BackgroundT‐cadherin modulates hepatocyte functions in vitro
Khetani, S. R., Chen, A. A., Ranscht, B., & Bhatia, S. N. (2008) · The FASEB Journal · doi:10.1096/fj.07-105155 · Cited by 57
Self-citationMathur, A., Loskill, P., Hong, S., Lee, J. Y., Marcus, S. G., Dumont, L., Conklin, B. R., Willenbring, H., Lee, L. P., & Healy, K. E. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt375 · Cited by 56
Eschbach, E., Chatterjee, S. S., Nöldner, M., Gottwald, E., Dertinger, H., Weibezahn, K., & Knedlitschek, G. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20360 · Cited by 54 · cited 3×
“For instance, Eschbach et al.(140) designed a planar polymer scaffold with 900 microcontainers encompassing laser-drilled wells for perfused culture of 3D hepatic aggregates of fairly uniform sizes.”
BackgroundInfluentialTrask, O. J., Moore, A., & LeCluyse, E. L. (2014) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2013.525 · Cited by 53 · cited 2×
“HCS approaches have recently been adapted to micropatterned cocultures of PHHs and 3T3-J2 fibroblasts.(62,115) The development of computational algorithms, designed to separate out the fluorescent intensities from multiple cell types in cocultures, has now set the precedence for using HCS in more sophisticated multice…”
BackgroundMethodSchug, M., Heise, T., Bauer, A., Storm, D., Blaszkewicz, M., Bedawy, E., Brulport, M., Geppert, B., Hermes, M., Föllmann, W., et al. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0375-x · Cited by 52 · cited 1×
“Indeed, one study found significant gene expression changes when hepatocytes were cultured on collagen as opposed to Matrigel, thereby showing that the culture platform is an important consideration for TGx studies using hepatocytes.(190) Functionally stable engineered liver models may address such shortcomings in usi…”
BackgroundCorcoran, J., Lange, A., Winter, M. J., & Tyler, C. R. (2012) · Environmental Science & Technology · doi:10.1021/es3005305 · Cited by 52 · cited 1×
“However, fish hepatocyte models are inadequate for prediction of drug effects on humans due to species-specific differences in drug metabolism pathways.(28) Accordingly, in vitro comparisons of drug metabolism across different animal and human liver models are necessary prior to selecting a species for FDA-required in…”
BackgroundCooperation of Liver Cells in the Synthesis and Degradation of Eicosanoids
Kmieć, Z. (2001) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-642-56553-3_7 · Cited by 50
Amino acid‐mediated heterotypic interaction governs performance of a hepatic tissue model
Jindal, R., Nahmias, Y., Tilles, A. W., Berthiaume, F., & Yarmush, M. L. (2009) · The FASEB Journal · doi:10.1096/fj.08-114934 · Cited by 50
Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model
Edling, Y., Sivertsson, L., Butura, A., Ingelman‐Sundberg, M., & Ek, M. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.07.026 · Cited by 50
Nedderman, A. N. R., Dear, G. J., North, S. E., Obach, R. S., & Higton, D. M. (2011) · Xenobiotica · doi:10.3109/00498254.2011.562330 · Cited by 45
Precision-cut organ slices to investigate target organ injury
Vickers, A. E. M., & Fisher, R. L. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.4.687 · Cited by 44
Susceptibility of human liver cell cultures to hepatitis C virus infection
Carloni, G., Iacovacci, S., Sargiacomo, M., Ravagnan, G., Ponzetto, A., Peschle, C., & Battaglia, M. (1993) · Springer eBooks · doi:10.1007/978-3-7091-9312-9_4 · Cited by 43
van Midwoud, P. M., Merema, M. T., Verweij, N., Groothuis, G. M. M., & Verpoorte, E. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23053 · Cited by 42
Molecular Pathology of Liver Diseases
Nagy, L. E. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.020 · Cited by 41
Metabolites in Safety Testing: “MIST” for the Clinical Pharmacologist
Frederick, C. B., & Obach, R. S. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.283 · Cited by 41
Larkin, A. L., Rodrigues, R. R., Murali, T. M., & Rajagopalan, P. (2013) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2012.0700 · Cited by 40
Toxicogenomics Strategies for Predicting Drug Toxicity
Martin, R. B., Rose, D. M., Yu, K., & Barros, S. A. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.7.1003 · Cited by 39 · cited 1×
“The majority of TGx studies have been performed in rats.(185,186) However, while the proof of concept has been established for the value of TGx in preclinical drug development, the sensitivity of DILI predictions between rats and humans has not been adequate, presumably due to the species-specific differences in drug…”
BackgroundCellular models for ADMET predictions and evaluation of drug-drug interactions.
Rj, R., & Kenna, J. G. (2004) · PubMed · Cited by 38
Evaluation of the metabolism and hepatotoxicity of xenobiotics utilizing precision-cut slices
Lake, B. G., & Price, R. J. (2012) · Xenobiotica · doi:10.3109/00498254.2012.734643 · Cited by 33
Microengineering in Biotechnology
(2009) · Methods in molecular biology · doi:10.1007/978-1-60327-106-6 · Cited by 29
Serralta, A. S., Donato, M. T., Martinez, A., Pareja, E., Orbís, F., Castell, J. V., Mir, J., & Gómez-Lechón, M. J. (2005) · Cell Transplantation · doi:10.3727/000000005783982495 · Cited by 27
Langsch, A., Giri, S., Açıkgöz, A., Jasmund, I., Frericks, B. B., & Bader, A. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.03.022 · Cited by 21
Subramanian, K., Raghavan, S., Bhat, A. R., Das, S., Dikshit, J. B., Kumar, R., Narasimha, M. K., Nalini, R., Radhakrishnan, R., & Raghunathan, S. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740330802501211 · Cited by 21 · cited 1×
“Strand Life Sciences (Bengaluru, India) has commercialized “Virtual Liver” software that contains a mathematical model of normal liver physiology with pathways for oxidative stress, cholestasis, steatosis (fat accumulation), energy depletion, and cytoskeletal maintenance.(198) When coupled with assays on specific cell…”
BackgroundOrganotypic systems in drug metabolism and toxicity: challenges and opportunities
Dash, A., Blackman, B. R., & Wamhoff, B. R. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.693161 · Cited by 21 · cited 2×
“Since then, as illustrated with examples above, several attempts have been made to mimic one or more of these cues in vitro depending on the application at hand and throughput desired.(11,12,94) As a result of such research, the use of in vitro liver models in drug development and other life science applications has s…”
BackgroundMethodBartlett, D. C., Hodson, J. A., Bhogal, R. H., Youster, J., & Newsome, P. N. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.01.006 · Cited by 19 · cited 1×
“A recent study showed that addition of an antioxidant, N-acetylcysteine, and replacement of collagenase with Liberase could increase the cell viability from both normal and diseased liver tissues.(65) PHHs have also been isolated from fibrotic and fatty livers, providing the ability to compare cells with a history of…”
BackgroundStrategies to produce hepatocytes and hepatocyte‐like cells from pluripotent stem cells
Chistiakov, D. A., & Chistiakov, P. A. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00896.x · Cited by 19
Research works printed but not linked: 2
- Guguen-Guillouzo, 2010, General Review on In Vitro Hepatocyte Models and Their Applications, Methods Mol. Biol., 640, 1, 10.1007/978-1-60761-688-7_1 · DOI · Paper page
- Berger, D. R., Ware, B. R., Davidson, M. D., et al. Enhancing the Functional Maturity of iPSC-Derived Human Hepatocytes via Controlled Presentation of Cell-Cell Interactions In Vitro. Hepatology, in press.
Cited by
Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment
Huang, G., Li, F., Zhao, X., Ma, Y., Li, Y., Lin, M., Jin, G., Lu, T. J., Genin, G. M., & Xu, F. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00094 · Cited by 825
Bell, C. C., Hendriks, D. F. G., Moro, S. M. L., Ellis, E., Walsh, J., Renblom, A., Fredriksson Puigvert, L., Dankers, A. C. A., Jacobs, F., Snoeys, J., et al. (2016) · Scientific Reports · doi:10.1038/srep25187 · Cited by 739
Recent Advances in Body-on-a-Chip Systems
Sung, J. H., Wang, Y. I., Narasimhan Sriram, N., Jackson, M., Long, C., Hickman, J. J., & Shuler, M. L. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05293 · Cited by 268
Narayanamurthy, V., Jeroish, Z. E., Bhuvaneshwari, K. S., Bayat, P., Premkumar, R., Samsuri, F., & Yusoff, M. M. (2020) · RSC Advances · doi:10.1039/d0ra00263a · Cited by 233
Beckwitt, C. H., Clark, A. M., Wheeler, S., Taylor, D. L., Stolz, D. B., Griffith, L., & Wells, A. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.12.023 · Cited by 208
Metadata
- Authors
- Khetani, S. R., Berger, D. R., Ballinger, K. R., Davidson, M. D., Lin, C., & Ware, B. R.
- Affiliations
- Colorado State University (US)
- Corresponding author
- Khetani, Salman R.
- Venue
- SLAS Technology
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 20
- Issue
- 3
- Pages
- 216-250
- ISSN
- 2472-6303 (ISSN-L)
- OpenAlex
- W2114732687
- Cited by
- 116
- References
- 210
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 1 · 2023: 7 · 2022: 13 · 2021: 13 · 2020: 13 · 2019: 7 · 2018: 14 · 2017: 11 · 2016: 18 · 2015: 8
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 2497 d)
- Locations
- SLAS TECHNOLOGY (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- drug-induced liver injury, organ-on-a-chip, hepatocyte-like cells, stem cell-derived hepatocytes, primary hepatocytes, cell lines, drug metabolism, drug toxicity, drug screening, microenvironment control, miniaturization, personalized drug testing
- MeSH terms
- Animals, Drug Evaluation, Preclinical, Humans, Liver, Miniaturization, Stem Cells, Hepatocytes, Tissue Engineering, Systems Biology, Chemical and Drug Induced Liver Injury, Lab-On-A-Chip Devices, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.